Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer.
Drain AP, Zahir N, Northey JJ, Zhang H, Huang P-J, Maller O, Lakins JN, Yu X, Leight JL, Alston-Mills BP, et al. Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer. J Exp Med. 2021;218(5).